Interleukin-6 in Critical Coronavirus Disease 2019, a Driver of Lung Inflammation of Systemic Origin?

OBJECTIVES:. To examine whether interleukin-6 in critical coronavirus disease 2019 is higher in arterial than in central venous blood, as a sign of predominantly local pulmonal rather than systemic interleukin-6 production. DESIGN:. Prospective cohort pilot study with repeated weekly measurements of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nikolai Ravn Aarskog, MD, Hans Christian Aass, PhD, Jan Cato Holter, MD, PhD, Morten Rostrup, MD, PhD, Aleksander Rygh Holten, MD, PhD
Formato: article
Lenguaje:EN
Publicado: Wolters Kluwer 2021
Materias:
Acceso en línea:https://doaj.org/article/77ff7ef076ce42c0bd7b814e4a482e9c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!